Issue Archive
Table of Contents
BLOOD ADVANCES TALK
Extended therapy for unprovoked venous thromboembolism: when is it indicated?
In this issue’s Blood Advances Talk, Tritschler and Wells discuss the role of extended therapy beyond the typical 3 months for patients with unprovoked venous thromboembolism. We hope you enjoy this discussion.
EXCEPTIONAL CASE REPORT
Bone marrow fibrosis associated with long-term imatinib therapy: resolution after switching to a second-generation TKI
Clinical Trials & Observations
STIMULUS REPORTS
Successful in utero stem cell transplantation in X-linked severe combined immunodeficiency
In utero stem cell transplantation holds promise to treat a broad range of congenital disorders. In a Stimulus Report, Magnani and colleagues describe a case of severe combined immunodeficiency successfully treated in utero using bone marrow from a matched sibling donor.
CLINICAL TRIALS AND OBSERVATIONS
Randomized study of imatinib for chronic myeloid leukemia: comparing standard dose escalation with aggressive escalation
Clinical Trials & Observations
GENE THERAPY
Baboon envelope LVs efficiently transduced human adult, fetal, and progenitor T cells and corrected SCID-X1 T-cell deficiency
HEMATOPOIESIS AND STEM CELLS
RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs
RUNX1 mutations are known to contribute to leukemic transformation. Vellenga and colleagues introduce the RUNX1-S291fs300X mutation into human CD34+ cells and induced pluripotent stem cells to study its role in leukemogenesis. The mutation has important biological effects.
HIF prolyl hydroxylase inhibitor FG-4497 enhances mouse hematopoietic stem cell mobilization via VEGFR2/KDR
LYMPHOID NEOPLASIA
MYD88 L265P mutation and CDKN2A loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas
Genome-wide promoter methylation of hairy cell leukemia
Hairy cell leukemia (HCL) is a tumor of mature B cells. The role of DNA methylation in this leukemia is explored by Forconi and colleagues to identify a methylation-driven signature of this HCL to better characterize this disease and aid future drug development efforts.
Anti–BAFF-R antibody VAY-736 demonstrates promising preclinical activity in CLL and enhances effectiveness of ibrutinib
MYELOID NEOPLASIA
Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia
Nicotinamide phosphoribosyltransferase is involved in the generation of NAD and is a potential target in acute myeloid leukemia (AML). Mitchell and colleagues evaluated a novel inhibitor, KPT-9274, in preclinical models that holds promise in future clinical studies of patients with AML.
Invariant phenotype and molecular association of biallelic TET2 mutant myeloid neoplasia
Mouse acute leukemia develops independent of self-renewal and differentiation potentials in hematopoietic stem and progenitor cells
The cell of origin of leukemic transformation is an area of ongoing debate. The study from the laboratory of Ema and colleagues explores the impact of self renewal and differentiation potentials in leukemia development and highlights the multiple cells of origin from which transformation can occur.
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
PLATELETS AND THROMBOPOIESIS
Calpain cleaves phospholipid flippase ATP8A1 during apoptosis in platelets
The asymmetric distribution of specific phospholipids on the cell surface is maintained through phospholipid flippases. Broer and colleagues studied the flippase ATP8A1 in murine and human platelets, revealing a novel mechanism of flippase cleavage that differed between activated and apoptotic platelets.
Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα
THROMBOSIS AND HEMOSTASIS
Reduced bone formation in males and increased bone resorption in females drive bone loss in hemophilia A mice
Platelets inhibit apoptotic lung epithelial cell death and protect mice against infection-induced lung injury
Platelets have been identified with diverse functions in coagulation, host tissue repair, and immune activity. Lee and colleagues report another important finding related to platelet function in animal models of lung disease. They find platelets protect against lung injury from pathogen-secreted virulence factors.
TRANSPLANTATION
Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients
Clinical Trials & Observations
Malglycemia, defined as hyperglycemia or hypoglycemia, is associated with increased complications of adult patients in many clinical settings. Forlenza and colleagues studied the impact of malglycemia in a cohort of pediatric and adolescent hematopoietic stem cell transplant patients, finding the disorder is associated with increased risk of morbidity and mortality in these patients too.
PTCy-based haploidentical vs matched related or unrelated donor reduced-intensity conditioning transplant for DLBCL
Clinical Trials & Observations
High probability of follow-up termination among AYA survivors after allogeneic hematopoietic cell transplantation
Clinical Trials & Observations
ERRATUM
-
Cover Image
Cover Image
COVER FIGURE
Colocalization of Ly6G and β2 integrins on neutrophils isolated from mice treated with Escherichia coli. See the article by Cunin et al. - PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Advertisement intended for health care professionals